Expert Interviews

Andel, principal of CommonHealth Solutions LLC, weighed in on potential strategies and challenges for Part D plans in navigating medication formulary limitations during catastrophic coverage phases in this second part of a two-part video series.

Ross Margulies, J.D., M.P.H., a partner at the Foley Hoag law firm, discusses whether proposed transparency rules in the pharmacy benefit manager (PBM) legislation that Congress is considering might apply to the PBM-affiliated group purchasing organizations.

Mahsa Salsabili, PharmD, PhD, underscores the potential cost-effectiveness of treatment through the adoption of prescription digital therapeutics, while acknowledging that additional evidence is required to conclusively determine their cost-effectiveness.

A medical professional reviews the clinical application of prescription digital therapeutics in both monotherapy and adjunct therapy roles, emphasizing their potential for stand-alone treatment in substance abuse and other chronic illnesses, while also noting their complementary role in conjunction with other treatments as adjunct therapy.

The Access to Prescription Digital Therapeutics Act remains a top priority for the Academy of Managed Care Pharmacy (AMCP), according to Jennifer L. Mathieu, AMCP senior vice president of professional and government affairs.

A medical expert explores the development of prescription digital therapeutic models, including insurance investment in prescription digital therapeutics and telemedicine, as well as employer-sponsored benefits for non-prescription digital therapeutics and wellness initiatives aimed at improving overall health outcomes.

Diana Brixner, PhD, FAMCP, examines the payer perspective on including Prescription Digital Therapeutics in formularies, utilizing real-world evidence as a key metric to assess the impact, cost-effectiveness, and patient benefit of these innovative digital treatments.

A medical professional examines the potential for cost-effective frontline treatments and personalized care delivered through a mobile application at the patient's own pace, emphasizing the significance of high self-motivation and patient activation, while also discussing the role of prescription digital therapeutics in adjunct therapy.

Mahsa Salsabili, PharmD, PhD, presents an overview of prescription digital therapeutics and their application in addressing unmet patient needs across various disease states, including diabetes, addiction, and mental health conditions.

Estay Greene, PharmD, MBA, offers key takeaways and provides closing thoughts on remaining unmet needs in the treatment of patients with diabetes.

Insights on how payers can allocate their resources to best improve outcomes for patients with diabetes.

Dr Brixner expands on evidence thresholds in the digital therapeutic space.

Diana Brixner, PhD, FAMCP, of the University of Utah opens a discussion surrounding digital therapeutics.

Payer perspectives on the challenges and advantages of integrating continuous glucose monitoring into diabetes management programs, highlighting the navigation of prior authorization requirements.

An expert on the treatment of diabetes offers insights on utilizing data to reveal disparities in care based on factors such as demographics and location.

Estay Greene, PharmD, MBA, outlines the main barriers that need to be addressed from a payer perspective in the treatment of high-risk patients with diabetes.

Mohannad Kusti, MD, examines opportunities to embrace recent innovations like telehealth consultations, remote monitoring, and clinical partnerships with top fertility clinics and research institutions to enable cutting-edge, personalized treatment plans.

Mohannad Kusti, MD, examines how comprehensive fertility benefits empower talent retention, yield a competitive edge, help prevent negative complications from improper fertility care, and mitigate costs from resulting absenteeism.

A medical expert discusses recent data and shared testimonials to educate employers on the value of fertility benefits, including contributions to diversity, equity, and inclusion.

Mohannad Kusti, MD, clarifies misconceptions around fertility benefits and their role in attracting, retaining, and empowering top talent.

Mohannad Kusti, MD, examines gaps in employer fertility coverage and reshaping employer perspective on fertility benefits.

Janet Choi, MD, gives closing thoughts on innovations in fertility benefits.

Janet Choi, M.D., spotlights the vital role of patient advocates in navigating fertility benefits and tackling care access gaps exacerbated by economic barriers, inadequate coverage and lack of emotional support throughout assisted reproductive treatment.

Janet Choi, M.D., examines enhancing the fertility patient experience and medical access from preconception through birth by reducing delays and barriers across the assisted reproductive treatment journey.

Expert, Janet Choi, M.D., advocates expanding financial coverage for inclusive fertility services to LGBTQ+ individuals and prospective single parents by choice seeking assistance to start families, countering disparities by making evidence-based treatments more accessible.

Janet Choi, M.D., discusses patient cost burden for fertility care and factors that may help reduce preterm births and miscarriages.